Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04756804 · ClinicalTrials.gov registry record · Phase 3
Perioperative Patient Skin Antiseptic Preparation Evaluation
A Phase 3 study, sponsored by Zurex Pharma.
- Completed
- Registry status
- Phase 3
- Development phase
- 51
- Enrollment target
NCT04756804: Completed Phase 3 study, sponsored by Zurex Pharma.
NCT04756804 is a Phase 3 study that has completed, run by Zurex Pharma. The registered enrollment target is 51 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04756804, a Phase 3 study, has completed, sponsored by Zurex Pharma.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 51 participants
- Enrollment target
Study Summary
This study will evaluate a new topical skin antiseptic perioperative preparation and the standard of care to determine efficacy on the rates of surgical site infections of surgical patients. Safety will also be assessed.
Primary Outcome
The primary objective is to demonstrate efficacy in surgical use through the rate of surgical site infections.
Interventions
- DRUG 70% v/v Isopropyl Alcohol Surgical Solution
- DRUG 2%w/v Chlorhexidine Gluconate / 70% v/v Isopropyl Alcohol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2021-06-21 |
| Est. Completion | 2022-09-29 |
| Phase | Phase 3 |
What the finished NCT04756804 record still lists
NCT04756804 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which 70% v/v Isopropyl Alcohol Surgical Solution is the first listed.
NCT04756804 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04756804 about?
NCT04756804 is a clinical study titled "Perioperative Patient Skin Antiseptic Preparation Evaluation". This study will evaluate a new topical skin antiseptic perioperative preparation and the standard of care to determine efficacy on the rates of surgical site infections of surgical patients. Safety will also be assessed.
What is the current status of trial NCT04756804?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 51 participants. The study started on 2021-06-21. Estimated completion is 2022-09-29.
What interventions are being tested in trial NCT04756804?
The interventions under investigation include: 70% v/v Isopropyl Alcohol Surgical Solution (DRUG), 2%w/v Chlorhexidine Gluconate / 70% v/v Isopropyl Alcohol (DRUG).
Who is sponsoring clinical trial NCT04756804?
This trial is sponsored by Zurex Pharma, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04756804's enrollment target sits among peer trials
51 1842nd of 2000 higher than 157 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI